Analysis of health-related quality of life (HRQoL) in advanced stage cervical cancer patients in Riau Province, Indonesia

In Indonesia, cervical cancer is the second most common malignancy after breast cancer. About 70% of cervical cancers are diagnosed at an advanced stage, which leads to treatment failures and negatively impacts patients quality of life and health. In order to determine if certain patient features affect health-related quality of life, this study aims to quantify the utility of patients with advanced cervical cancer. This study employs a cross-sectional design and a descriptive-analytic approach to quantitative observational research. Non-Probability Sampling with Purposive Sampling was used to get the study's final sample size of 135. The study found that cervical cancer negatively affects health-related quality of life, with an average EQ-5D-5L utility value of 0.4653 and a VAS utility value of 0.6850. Discomfort or pain was the most common health issue (42.2%), followed by emotional distress (29.6%). Patients ages were shown to have a significant (p0.05) effect on the utility of the EQ-5D-5L and the VAS. However, patients occupational status and chemotherapy type were found to have no such effects on the usability of the instruments. When comparing EQ-5D-5L and VAS, however, we find no significant difference (p>0.05) in education level and long-suffering characteristics.